Commercial Services Healthcare Sector

Eupraxia Pharmaceuticals

Market Cap: CA$185.0m

A clinical-stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.

Aldeyra Therapeutics

Market Cap: US$134.8m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Prenetics Global

Market Cap: US$134.4m

A consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.

DocGo

Market Cap: US$132.8m

Provides mobile health and medical transportation services in the United States and the United Kingdom.

Vireo Growth

Market Cap: CA$181.8m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Exagen

Market Cap: US$131.8m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

TuHURA Biosciences

Market Cap: US$131.5m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Protalix BioTherapeutics

Market Cap: US$131.4m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Atlantic International

Market Cap: US$131.1m

Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.

Greenwich LifeSciences

Market Cap: US$131.0m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

Alector

Market Cap: US$131.0m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Ventyx Biosciences

Market Cap: US$129.5m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

Oneview Healthcare

Market Cap: AU$197.8m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.

Anteris Technologies Global

Market Cap: AU$195.1m

A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

Pulmonx

Market Cap: US$125.6m

A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

KORU Medical Systems

Market Cap: US$125.5m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

Nkarta

Market Cap: US$125.2m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Lyell Immunopharma

Market Cap: US$124.8m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Seer

Market Cap: US$124.3m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

Jin Medical International

Market Cap: US$124.3m

Engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury.

Larimar Therapeutics

Market Cap: US$123.6m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

InflaRx

Market Cap: US$123.3m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Enanta Pharmaceuticals

Market Cap: US$122.9m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Nektar Therapeutics

Market Cap: US$122.8m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Protara Therapeutics

Market Cap: US$122.3m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

eXoZymes

Market Cap: US$122.2m

A development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.

InfuSystem Holdings

Market Cap: US$121.7m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

Theratechnologies

Market Cap: CA$165.5m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

AOTI

Market Cap: UK£87.7m

Produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers worldwide.

Sangamo Therapeutics

Market Cap: US$117.5m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Black Diamond Therapeutics

Market Cap: US$117.1m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

Neumora Therapeutics

Market Cap: US$116.1m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

American Well

Market Cap: US$115.5m

An enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

Myomo

Market Cap: US$115.5m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

Global Cord Blood

Market Cap: US$113.8m

Provides umbilical cord blood storage and ancillary services in the People's Republic of China.

RAPT Therapeutics

Market Cap: US$113.5m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.